207 related articles for article (PubMed ID: 22484226)
1. Susceptibility to cervical cancer: an overview.
de Freitas AC; Gurgel AP; Chagas BS; Coimbra EC; do Amaral CM
Gynecol Oncol; 2012 Aug; 126(2):304-11. PubMed ID: 22484226
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study.
Machalek DA; Wark JD; Tabrizi SN; Hopper JL; Bui M; Dite GS; Cornall AM; Pitts M; Gertig D; Erbas B; Garland SM
Twin Res Hum Genet; 2017 Feb; 20(1):10-18. PubMed ID: 27917752
[TBL] [Abstract][Full Text] [Related]
3. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women.
Dankai W; Khunamornpong S; Siriaunkgul S; Soongkhaw A; Janpanao A; Utaipat U; Kitkumthorn N; Mutirangura A; Srisomboon J; Lekawanvijit S
PLoS One; 2019; 14(1):e0210289. PubMed ID: 30608989
[TBL] [Abstract][Full Text] [Related]
4. Identification of HPV Integration and Genomic Patterns Delineating the Clinical Landscape of Cervical Cancer.
Akeel RA
Asian Pac J Cancer Prev; 2015; 16(18):8041-5. PubMed ID: 26745036
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in cervical cancer.
Wani K; Nair CK
Indian J Exp Biol; 2003 Aug; 41(8):789-96. PubMed ID: 15248474
[TBL] [Abstract][Full Text] [Related]
6. HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer.
de Araujo Souza PS; Sichero L; Maciag PC
Future Oncol; 2009 Apr; 5(3):359-70. PubMed ID: 19374542
[TBL] [Abstract][Full Text] [Related]
7. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
[TBL] [Abstract][Full Text] [Related]
9. Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix.
Stanczuk GA; Kay P; Sibanda E; Allan B; Chirara M; Tswana SA; Bergstrom S; Williamson AL
Acta Obstet Gynecol Scand; 2003 Aug; 82(8):762-6. PubMed ID: 12848649
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of cervical cancer.
Ibeanu OA
Cancer Biol Ther; 2011 Feb; 11(3):295-306. PubMed ID: 21239888
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus (HPV) and cervical cancer.
Wardak S
Med Dosw Mikrobiol; 2016; 68(1):73-84. PubMed ID: 28146625
[TBL] [Abstract][Full Text] [Related]
12. The role of human papilloma virus (HPV) in the aetiology of cervical cancer.
Malik AI
J Pak Med Assoc; 2005 Dec; 55(12):553-8. PubMed ID: 16438278
[No Abstract] [Full Text] [Related]
13. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
14. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
16. Environmental co-factors in HPV carcinogenesis.
Castellsagué X; Bosch FX; Muñoz N
Virus Res; 2002 Nov; 89(2):191-9. PubMed ID: 12445659
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of tumor suppressor gene PML in uterine cervical carcinogenesis: impact of human papillomavirus infection (HPV).
Singh N; Sobti RC; Suri V; Nijhawan R; Sharma S; Das BC; Bharadwaj M; Hussain S
Gynecol Oncol; 2013 Mar; 128(3):420-6. PubMed ID: 23220564
[TBL] [Abstract][Full Text] [Related]
18. Association between RASSF1A Promoter Hypermethylation and Oncogenic HPV Infection Status in Invasive Cervical Cancer: a Meta-analysis.
Li JY; Huang T; Zhang C; Jiang DJ; Hong QX; Ji HH; Ye M; Duan SW
Asian Pac J Cancer Prev; 2015; 16(14):5749-54. PubMed ID: 26320446
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of human papillomavirus genotyping.
Choi YJ; Park JS
J Gynecol Oncol; 2016 Mar; 27(2):e21. PubMed ID: 26768784
[TBL] [Abstract][Full Text] [Related]
20. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
Wheeler CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
